Innovative Follow-up Strategies for Endometrial Cancer

A Collins; A Taylor; D S Guttery; E L Moss

doi:10.1016/j.clon.2021.06.001

Innovative Follow-up Strategies for Endometrial Cancer

Clin Oncol (R Coll Radiol). 2021 Sep;33(9):e383-e392. doi: 10.1016/j.clon.2021.06.001. Epub 2021 Jun 23.

Authors

A Collins¹, A Taylor², D S Guttery¹, E L Moss³

Affiliations

¹ Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
² Royal Marsden NHS Foundation Trust, London, UK.
³ Leicester Cancer Research Centre, University of Leicester, Leicester, UK. Electronic address: em321@le.ac.uk.

PMID: 34172343
DOI: 10.1016/j.clon.2021.06.001

Abstract

Increasing recognition of the heterogeneous nature of endometrial cancer, the excellent prognosis of low-risk cases and improvements in risk stratification offer opportunities for innovative, personalised follow-up strategies. This review article outlines the evidence base for alternative follow-up strategies in the different risk categories of endometrial cancer, cancer survivorship programmes and considers future directions in endometrial cancer follow-up, including emerging new techniques, such as the liquid biopsy, and opportunities for combining molecular and clinicopathological features to personalise endometrial cancer follow-up.

Keywords: Cancer survivorship; circulating tumour DNA; endometrial cancer; patient-initiated follow-up; recurrence; telephone follow-up.

Publication types

Review

MeSH terms

Endometrial Neoplasms*
Female
Follow-Up Studies
Humans
Neoplasm Recurrence, Local